POTASSIUM AMINOSALICYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Potassium Aminosalicylate, and when can generic versions of Potassium Aminosalicylate launch?
Potassium Aminosalicylate is a drug marketed by Hexcel and is included in one NDA.
The generic ingredient in POTASSIUM AMINOSALICYLATE is potassium aminosalicylate. There are two hundred and forty drug master file entries for this compound. Additional details are available on the potassium aminosalicylate profile page.
Summary for POTASSIUM AMINOSALICYLATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Patent Applications: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | POTASSIUM AMINOSALICYLATE at DailyMed |
US Patents and Regulatory Information for POTASSIUM AMINOSALICYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hexcel | POTASSIUM AMINOSALICYLATE | potassium aminosalicylate | POWDER;ORAL | 080098-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |